Tag: Blood Disorders
Misdiagnosis Common for Suspected Myelodysplastic Neoplasms
About one-third of cases were reclassified following central review; receipt of inappropriate meds reported in 7 percent of misdiagnosed cases
International Prognostic Scoring System-Molecular Changes Clinical Management
For nearly half of patients with myelodysplastic syndromes, results could change clinical care
Tranexamic Acid Does Not Up Functional Outcome After Major Trauma
No improvement seen in favorable functional outcome at six months, but reduced risk of death at 28 days after injury
Study Weighs Timing of Platelet Transfusion With Central Venous Catheter Placement
Withholding prophylactic platelet transfusion did not meet noninferiority in patients with severe thrombocytopenia
FDA Eases Rules on Gay Men Donating Blood
Policies are now in alignment with what already happens in some other countries, including U.K. and Canada
Idiopathic CD4 Lymphocytopenia Linked to Opportunistic Infection, Cancer
Reduced CD4 count linked to higher risk for opportunistic infection and invasive cancer, lower risk for autoimmunity
MRI-Based AI Can Distinguish Aplastic Anemia From MDS
IDEAL-IQ-based machine learning of pelvis can differentiate aplastic anemia from myelodysplastic syndromes
FDA Approves Cord Blood Stem Cell Product for Blood Cancer Patients
Omisirge speeds neutrophil recovery and cuts risk of infection
Donor Sex Does Not Affect Survival in Red-Cell Transfusion
Adjusted hazard ratio for death did not differ significantly for those receiving red cells from male or female donors
Interferon Alfa-2b Effective for Low-Grade Lymphomatoid Granulomatosis
61 percent of patients had complete response to interferon alfa-2b; patients with high-grade disease showed expected response to chemo
